» Articles » PMID: 39858825

A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth

Overview
Journal Microorganisms
Date 2025 Jan 25
PMID 39858825
Authors
Affiliations
Soon will be listed here.
Abstract

Small intestinal bacterial overgrowth (SIBO) is a disorder characterized by the excessive growth of bacteria in the small intestine. Bacterial overgrowth disrupts the bacterial balance and can lead to abdominal pain, weight loss, and gastrointestinal symptoms, including bloating, diarrhea, and malabsorption. SIBO is widespread in the population. There are two main methods for diagnosing SIBO: breath tests and bacterial culture. The most commonly used method is a breath test, which enables the division of SIBO into the following three types: hydrogen-dominant (H-SIBO), methane-dominant (CH-SIBO), and hydrogen/methane-dominant (H/CH-SIBO). This comprehensive review aims to present the current knowledge on the use of prebiotics, probiotics, and postbiotics in the context of SIBO. For this purpose, medical databases such as MEDLINE (PubMed) and Scopus were analyzed using specific keywords and their combinations. This review is based on research studies no older than 10 years old and those using only human models. In summary, clinical studies have shown that the efficacy of SIBO therapy can be increased by combining antibiotics with probiotics, especially in vulnerable patients such as children and pregnant women. The further development of diagnostic methods, such as point of care testing (POCT) and portable devices, and a better understanding of the mechanisms of biotics action are needed to treat SIBO more effectively and improve the quality of life of patients.

References
1.
Redondo-Cuevas L, Belloch L, Martin-Carbonell V, Nicolas A, Alexandra I, Sanchis L . Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial. Nutrients. 2024; 16(7). PMC: 11013329. DOI: 10.3390/nu16071083. View

2.
Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A . Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023; 29(22):3400-3421. PMC: 10303511. DOI: 10.3748/wjg.v29.i22.3400. View

3.
Shah S, Day L, Somsouk M, Sewell J . Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013; 38(8):925-34. PMC: 3819138. DOI: 10.1111/apt.12479. View

4.
Prajapati N, Patel J, Singh S, Yadav V, Joshi C, Patani A . Postbiotic production: harnessing the power of microbial metabolites for health applications. Front Microbiol. 2024; 14:1306192. PMC: 10758465. DOI: 10.3389/fmicb.2023.1306192. View

5.
Van Loo J . Prebiotics promote good health: the basis, the potential, and the emerging evidence. J Clin Gastroenterol. 2004; 38(6 Suppl):S70-5. DOI: 10.1097/01.mcg.0000128928.99037.e6. View